mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.3 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.054 |
0.3 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |